Annemieke Aartsma-rus MSc, PhD

Prof.dr. Annemieke Aartsma-Rus played an important role in the development of the antisense-mediated exon skipping therapy for Duchenne muscular dystrophy during her Ph.D. research (2000-2004) at the Leiden University Medical Center, Department of Human Genetics (the Netherlands). As of December 2007, she became the leader of the “DMD exon skip group” first, as an assistant professor and currently as a professor at the Department of Human Genetics. Since 2013 she has a visiting professorship at the Institute of Genetic Medicine of Newcastle University (UK). In 2015 she was selected as the most influential scientist in Duchenne muscular dystrophy in the past 10 years (2006-2015) by Expertscape based on contributions to the understanding and treatment of Duchenne muscular dystrophy. In 2011 she received the Duchenne Award from the Dutch Duchenne Parent Project in recognition of this work and her dedication to the Duchenne field.